EUVIMEDEUVIMED entdecken
Leitlinie

Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society

Alina Kułakowska, Dagmara Mirowska-Guzel iD, Alicja Kalinowska, Halina Bartosik-Psujek, Waldemar Brola, Mariusz Stasiolek, Andrzej Głąbiński, Jacek Losy, Andrzej Potemkowski, Konrad Rejdak, Iwona Sarzyńska-Długosz, Małgorzata Siger und 5 weitere

Neurologia i Neurochirurgia Polska · 2024

DOI: 10.5603/pjnns.102356 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Neurologia i Neurochirurgia Polska, 2024. Verfasst von Alina Kułakowska und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Bialystok, Bialystok, Poland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurology. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of multiple sclerosis (MS) has undergone significant changes since the first disease-modifying therapy (DMT) drug was introduced. Currently, 19 original DMT drugs are registered in the European Union. The choice of optimal therapy is becoming increasingly challenging in the absence of reliable biomarkers on the basis of which disease progression and prognosis can be determined. In addition, longer availability and a growing number of drugs used in MS mean that doctors and patients may have to change therapy when the treatment is ineffective or is associated with the occurrence of adverse effects. The ageing of the MS population, comorbidities, and administration of other drugs during DMT should also be considered. This paper presents recommendations for initiating, monitoring, changing and possibly discontinuing DMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisNeurologyHumansImmunologic FactorsPolandSocieties, Medical

Stichwörter der Autor:innen

clinically isolated syndromedisease-modifying therapymultiple sclerosisprimary progressive multiple sclerosisradiologically isolated syndromerecommendationsrelapsing-remitting multiple sclerosissecondary progressive multiple sclerosis

Substanzen

Immunologic Factors

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Bialystok, Bialystok, Poland.
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland. dmirowska@wum.edu.pl.
  • Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Neurology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
  • Collegium Medicum Jan Kochanowski University of Kielce, Kielce, Poland.
  • Department of Neurology and Stroke, Medical University of Lodz, Lodz, Poland.

ORCID-Profile: Dagmara Mirowska-Guzel

Zitieren

APA

Kułakowska, A., Mirowska-Guzel, D., Kalinowska, A., Bartosik-Psujek, H., Brola, W., Stasiolek, M., Głąbiński, A., Losy, J., Potemkowski, A., Rejdak, K., Sarzyńska-Długosz, I., Siger, M., Stępień, A., Wawrzyniak, S., Zaborski, J., Zakrzewska-Pniewska, B., & Adamczyk-Sowa, M. (2024). Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society. Neurologia i Neurochirurgia Polska. https://doi.org/10.5603/pjnns.102356

Vancouver

Kułakowska A, Mirowska-Guzel D, Kalinowska A, Bartosik-Psujek H, Brola W, Stasiolek M, et al. Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society. Neurologia i Neurochirurgia Polska. 2024. doi:10.5603/pjnns.102356

BibTeX
@article{Kuakowska2024,
  author = {Kułakowska, Alina and Mirowska-Guzel, Dagmara and Kalinowska, Alicja and Bartosik-Psujek, Halina and Brola, Waldemar and Stasiolek, Mariusz and Głąbiński, Andrzej and Losy, Jacek and Potemkowski, Andrzej and Rejdak, Konrad and Sarzyńska-Długosz, Iwona and Siger, Małgorzata and Stępień, Adam and Wawrzyniak, Sławomir and Zaborski, Jacek and Zakrzewska-Pniewska, Beata and Adamczyk-Sowa, Monika},
  title = {Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society},
  journal = {Neurologia i Neurochirurgia Polska},
  year = {2024},
  doi = {10.5603/pjnns.102356}
}
Kostenlos starten →